News By Tag Industry News News By Location Country(s) Industry News
| Constipation-Pipeline Insights, 2015 - A DelveInsight’s ReportDelveInsight, the leading market research and consulting company has added a new report “Constipation-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.
By: DelveInsight Business Research • The information of around 28 pipeline drugs with 20+ companies involved in drug development. There are 4 drugs in Phase III, 10 in Phase II, 5 in Phase I, 3 discontinued and 6 dormant drugs. • Elobixibat developed by Ferring pharmaceuticals is under Phase III clinical trial. • KWA0711 developed by Kissei pharmaceuticalsand SYN-010 developed bySynthetic Biologics are under Phase II clinical trial. • R& • Stages of development of pipeline molecules. • Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. • Information related to collaborations, in-licensing and out-licensing deals. DelveInsight’ DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License. For more information on Pipeline Insight Reports, email at info@delveInsight.com Contact Us: DelveInsight Business Research New Delhi-110075, India Phone: +91-11-45689769, +91 9650213330 Website: http://delveinsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making, identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients. End
|
|